NeVa: More & More are Training to #DoTheDropZone
A growing number of European & Middle Eastern doctors and stroke teams are training to #DoTheDropZone with NeVa, a revolutionary thrombectomy device with high first pass rates.
Vesalio Reports 2,500 Patient Milestone
Vesalio reports it has surpassed 2,500 clinical cases with the NeVa™ neuro-thrombectomy platform. Physicians have evaluated the Neva Drop Zone™ technology with enthusiasm as it has shown a unique capability of removing the full spectrum of clot types in large vessel occlusion ischemic stroke.
Another Successful Vesalio™ Clot Interaction Workshop in Barcelona
On January 22 and 23, a diverse group of physicians from 8 different countries trained on new approaches for clot retrieval with the NeVa™ Drop Zone Retrieval Technique at the Vesalio Clot Interaction Workshops that took place at the Vall d’Hebron Research Institute.
VESALIO Mood: Elated, Excited and Ready to Rock in 2020
As the end of 2019 approaches, we reflect with pride and gratitude on what we achieved: We saw the publication of our First in Man data and initiated our regulatory enabling studies, We received our 2nd CE mark on the expanded #NeVa platform, including designs with more Drop Zones, We organized 5 Vesalio Clot Interaction…
Vesalio and Vassa Medical celebrate NeVa™ Launch in Mirano, Italy
On April 5th, the Vassa Medical national sales network convened to celebrate the Italy launch of NeVa at the company’s headquarters in Mirano near Venice. Dr. Massimo Sponza from Udine Hospital was present to train the team on acute ischemic stroke and thrombectomy.
NeVa™ First Clinical Experience Data Presented at the International Stroke Conference
From Val D’Isere, France to Honolulu, Vesalio’s early clinical experience data is being presented globally.
NeVa™ Drop Zone Effect – Initial Experience Presented at ABC Win
On January 18, 2019, Professor Serdar Geyik (Istanbul Istinye University) presented his early NeVa experience at the ABC-WIN Seminar in Val D’Isere, France.
